Alveolar cells in cyclophosphamide-induced lung injury. An ultrastructural analysis of type II alveolar epithelial cells in situ

Histology and Histopathology

Volumn 13, Issue 1, 1998, Pages 13-20

  Sulkowska, M ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Cyclophosphamide; Lung; Type II pneumocyte; Ultrastructure

Indexed keywords

CYCLOPHOSPHAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; DRUG EFFECT; ELECTRON MICROSCOPY; INTRAPERITONEAL DRUG ADMINISTRATION; LUNG ALVEOLUS CELL TYPE 2; LUNG FIBROSIS; LUNG INJURY; MALE; NONHUMAN; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; CYCLOPHOSPHAMIDE; EPITHELIAL CELLS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAPERITONEAL; MALE; MICROSCOPY, ELECTRON; PULMONARY ALVEOLI; PULMONARY FIBROSIS; RATS; RATS, WISTAR;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0031983719     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Adamson I.Y.R., Young L. and Bowden D.H. (1988). Relationship of alveolar epithelial injury and repair to the induction of pulmonary fibrosis. Am. J. Pathol. 130, 377-383.
2. Bitterman P.B., Adelberg S. and Crystal R.G. (1983). Mechanisms of pulmonary fibrosis: Spontaneous release of the alveolar macrophage derived growth factor in the interstitial lung disorders. J. Clin. Invest. 72, 1801-1813.
3. Chander A. and Fisher A.B. (1990). Regulation of lung surfactant secretion. Am. J. Physiol. 258, 241-253.
4. Collis C.H., Wilson C.M. and Jones J.M. (1980). Cyclophosphamide-induced lung damage in mice: protection by a small preliminary dose. Br. J. Cancer 41, 901-907.